Weight loss drugs could at least double the risk of diabetic patients developing age-related macular degeneration, a large-scale study has found.
Originally developed for diabetes patients, glucagon-like peptide-1 receptor agonist (GLP-1 RA) medicines have transformed how obesity is treated and there is growing evidence of wider health benefits. They help reduce blood sugar levels, slow digestion and reduce appetite.
